The analysis of the TCGA Breast Cancer dataset demonstrated also a statistical significant difference between the two luminal subtypes and triple negative and HER2-amplified BCs, suggesting that miR-9 expression might be used to refine the breast cancer molecular classification. Here, ERBB2 is linked to breast carcinoma.